Skip to main content
Clinical Trials/NCT01669057
NCT01669057
Completed
Not Applicable

Case-control Study on Environmental and Genetic Factors of Congenital Heart Disease

Children's Hospital of Fudan University1 site in 1 country6,000 target enrollmentOctober 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congenital Heart Disease
Sponsor
Children's Hospital of Fudan University
Enrollment
6000
Locations
1
Primary Endpoint
genome-wide DNA SNPs and methylations
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The objective of this study is to investigate the effect of parental peri-natal environmental risk factors and genetic factors on the development of Congenital Heart Disease (CHD). Our hypothesis is that the distributions of some environmental and genetic risk factors significantly differ between neonates with and without CHD.

Detailed Description

Congenital heart defect (CHD) is one of birth defects in the structure of the heart and/or great vessels. Many types of heart defects exist, most of which either obstruct blood flow in the heart or vessels near it, or cause blood to flow through the heart in an abnormal pattern. Heart defects are the leading cause of birth defect-related infant deaths. So far people recognize that the causes of CHD are the conjunct effect of environment and genetic factors, both of which remain unclear. The current stud aims at investigating all the possible perinatal parental environmental risk factors and underlying genetic factors to CHD, including DNA variation and methylations. A hospital-based 1:1 matched case control study is conducted. Subjects were recruited through neonatal screening program, which includes a clinical symptom screening followed by a cardiac ultrasound diagnosis for those with at least one clinical indicator. The blood sample of participant will be collected and the parents of subjects will be interviewed to completed a questionnaire including general information and possible risk factors to CHD.

Registry
clinicaltrials.gov
Start Date
October 2011
End Date
August 2014
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Guoying huang

Professor,President

Children's Hospital of Fudan University

Eligibility Criteria

Inclusion Criteria

  • Han ethnic
  • 0\~3 years old
  • screened by 7 indicator, diagnosed by ultrasound

Exclusion Criteria

  • with other brith defects
  • with Patent Ductus Arteriosus (PDA) and Patent Foramen Ovale (PFO)
  • Control group
  • Inclusion Criteria:
  • Han ethnic
  • 0\~3 years old
  • without any of 7 screen indicator , without CHD heart palpitations and other complaints about heart disease, born in the same hospital with cases
  • Exclusion Criteria:
  • With other birth defects

Outcomes

Primary Outcomes

genome-wide DNA SNPs and methylations

Time Frame: delivery

DNA sample from neonate blood

perinatal supplements and drug using

Time Frame: three months before pregnancy till delivery

questionnaire including supplements and drug using for mother

Secondary Outcomes

  • birth weight(delivery)
  • gestational weeks(delivery)
  • Life risk factors of mother(three months before pregnancy till delivery)
  • Life risk factors of father(three months before pregnancy till delivery)

Study Sites (1)

Loading locations...

Similar Trials